Matthew R. Ritter
Corporate Officer/Principal presso EQUILLIUM, INC.
Profilo
Matthew R.
Ritter is currently working as the Senior Vice President-Corporate Development at Equillium, Inc. He previously worked as a Principal at Lonza, Inc. and as a Manager-Research & Development at EyeCyte, Inc. Dr. Ritter completed his undergraduate degree at the University of California, Irvine and obtained a doctorate degree from the Keck School of Medicine of USC.
Posizioni attive di Matthew R. Ritter
| Società | Posizione | Inizio |
|---|---|---|
| EQUILLIUM, INC. | Corporate Officer/Principal | - |
Precedenti posizioni note di Matthew R. Ritter
| Società | Posizione | Fine |
|---|---|---|
Lonza, Inc.
 Lonza, Inc. Chemicals: SpecialtyProcess Industries Lonza, Inc. provides chemical ingredient products. The company is headquartered in Allendale, NJ. | Corporate Officer/Principal | - |
EyeCyte, Inc.
 EyeCyte, Inc. Pharmaceuticals: MajorHealth Technology EyeCyte, Inc. develops products for the treatment of retinal disease. It focuses on treatments for age-related macular degeneration (AMD) and diabetic retinopathy. The company was founded by Mohammad El-Kalay and Martin Friedlander in 2008 and is headquartered in La Jolla, CA. | Chief Tech/Sci/R&D Officer | - |
Formazione di Matthew R. Ritter
| University of California, Irvine | Undergraduate Degree |
| Keck School of Medicine of USC | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| EQUILLIUM, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Lonza, Inc.
Lonza, Inc. Chemicals: SpecialtyProcess Industries Lonza, Inc. provides chemical ingredient products. The company is headquartered in Allendale, NJ. | Process Industries |
EyeCyte, Inc.
EyeCyte, Inc. Pharmaceuticals: MajorHealth Technology EyeCyte, Inc. develops products for the treatment of retinal disease. It focuses on treatments for age-related macular degeneration (AMD) and diabetic retinopathy. The company was founded by Mohammad El-Kalay and Martin Friedlander in 2008 and is headquartered in La Jolla, CA. | Health Technology |
- Borsa valori
- Insiders
- Matthew R. Ritter
